About Aesica
Aesica is a Healthcare company based in Newcastle Upon Tyne (United Kingdom) founded in 2004, and was acquired by Pharmaron in January 2023. Contract development and manufacturing organisation (CDMO) for APIs and finished dose forms. Aesica has completed 1 acquisition, including R5 Pharmaceuticals. Its chief executive, as recorded, is Manja Boerman. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its legal entity is PHARMARON MANUFACTURING SERVICES (UK) LTD.
Company details
Aesica is a pharmaceutical contract development and manufacturing organization (CDMO) for both APIs and finished dose forms.It offers end-to-end pharmaceutical development and manufacturing solution that comprises of capabilities in formulation development for API and finished dose, manufacturing at all scales and packaging services.it also offers end-to-end capabilities in the design, industrialization and manufacture of medical delivery device. Recently, the company won young achiever of the year chemical industry award.
- Headquarters Newcastle Upon Tyne, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website aesica-pharma.com
- Social LinkedIn X
- Acquired by Pharmaron (Jan 2023)
- Legal Name Pharmaron Manufacturing Services (Uk) Ltd
- Date of Incorporation 23 Jul, 2004
- Jurisdiction CRAMLINGTON, NORTHUMBERLAND, ENGLAND
- InvestorsPharmaron
& 1 more
- Investments & Acquisitions
- Acquired by
Investors in Aesica
Aesica has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Pharmaron and Consort Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Portfolio of products for airway management and drug delivery | 1946 | consortmedical.com | Hemel Hempstead, United Kingdom | |
Drug discovery and development services for small molecules are provided. | 2003 | pharmaron.com | Beijing, China |
Investor details for Aesica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aesica
228 people are tracked at Aesica (96 in leadership, 5 in board & advisors, 127 in team).
| Name | Role | Group |
|---|---|---|
Manja Boerman | CEO & MD | Leadership |
Ralf G. Liedke | Director IT | Leadership |
Neil Jones | Chief Commercial Officer (cco) | Leadership |
David M. | Production And Process Engineering Director / Industrial Operations | Leadership |
Teresa Karnatz | Business Development Director | Leadership |
Kieran Chouhan | General Manager, RPH Pharmaceuticals | Leadership |
Steven Harris | Associate Director Of Process Analytics, Mrna Vaccines | Leadership |
Gerardo Cappitella | Operations Director | Leadership |
Joaquim Mascaro | CFO | Leadership |
Vikas Gupta | President of ReciBioPharm | Leadership |
Luisa Amoedo | Head Of Biotech Operations | Leadership |
J.p. Fournier | Chief Financial Officer | Leadership |
Gian Luca Rossetto | HR Director | Leadership |
Edita B. | Head Of Process Analytical Technology & Data Science (continuous Manufacturing Mrna) | Leadership |
Daniel Nordbeck | Head Of IT Governance & Controlling | Leadership |
Jon Reed | Head Of Sales | Leadership |
Sylvia Godde | Director, Finance At Recibiopharm, A Business Unit Of Recipharm AB | Leadership |
Roberta Vigna | Global Quality Head Of Non Steriles | Leadership |
Aula al Muslim Celejewski | Associate Director | Leadership |
Claire Gama | Director Corporate Project Management SFF And OSD Sites | Leadership |
208 more people are available in the full profile.
Complete people profiles for Aesica
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aesica
Aesica has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include R5 Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Develops formulations for clinical trials ranging from solid-dose capsules to liquids and injectables | r5pharma.com | Nottingham, United Kingdom | 2006 | Jun 2010 | •••• |
Complete acquisition details for Aesica
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Aesica
4 dated milestones of Aesica across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Aesica is founded.
- Acquisition Acquires R5 Pharmaceuticals.
- Exit Acquired by Consort Medical.
- Exit Acquired by Pharmaron.
Web traffic of Aesica
Websites that share an audience with Aesica (aesica-pharma.com).
Websites whose visitors overlap most with Aesica. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nextpharma.com | 100% | 8K | #1,667,239 | View details | |
| lomapharm.de | 100% | 2K | #5,491,269 | View details | |
| fareva.com | 100% | 14.6K | #1,040,773 | View details | |
ursapharm.de | ursapharm.de | 66% | #780,498 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aesica
Complete news archive for Aesica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aesica
Aesica was founded in 2004.
Aesica is headquartered in Newcastle Upon Tyne, United Kingdom.
Manja Boerman is the CEO of Aesica, as recorded in our data.
Aesica is a pharmaceutical contract development and manufacturing organization (CDMO) for both APIs and finished dose forms.It offers end-to-end pharmaceutical development and manufacturing solution that comprises of capabilities in formulation development for API and finished dose, manufacturing at all scales and packaging services.it also offers end-to-end capabilities in the design, industrialization and manufacture of medical delivery device. Recently, the company won young achiever of the year chemical industry award.
Aesica has made 1 acquisition, including R5 Pharmaceuticals.
Aesica has 2 investors. Key investors include Pharmaron, and Consort Medical.
Aesica operates through Pharmaron Manufacturing Services (Uk) Ltd.
Yes. Aesica was acquired by Pharmaron in January 2023.